HomeJSWDULUX › Filing
🔔 Get instant alerts when JSWDULUX files quarterly results on BSE Start free trial →
JSW Dulux Limited (JSWDULUX)

Outcome of Board Meeting

Filed: 11 Aug 2026, 16:36 IST Exchange: NSE Category: Financial Results — Audited Results
FY2026 results (audited): Standalone: Revenue 36.0bn +x% y-y (35.99bn) PAT 19.2bn +x% y-y (19.18bn) Consolidated: Revenue 37.0bn +x% y-y (36.98bn) PAT 19.7bn +x% y-y (19.74bn) Q1FY2027 results (unaudited): Standalone: Revenue 9.7bn -2.8% y-y (9.9bn) EBITDA 1.15bn -14.4% y-y (1.35bn) PAT 1.36bn +48.8% y-y (0.91bn) Consolidated: Revenue 9.9bn -x% y-y (10.0bn) PAT 0.80bn -x% y-y (0.91bn) Dividend: Not stated Commentary: Q1 FY2026-27 started strong with double-digit volume and value growth, market share gains, and new product launches; Board approved stock split from Rs 10 to Rs 1 face value shares to enhance liquidity and broaden equity participation.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 JSWDULUX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add JSWDULUX to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on JSW Dulux Limited

Important. The summary above is generated automatically from JSW Dulux Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.